However, when a third of the participants were switched to a placebo for the following year, they regained 7% of the weight they had lost
It is unique because it is a dual-agonist of two important hormones: GLP-1 (Glucagon-like peptide-1): Similar to medications like semaglutide, it mimics this hormone, which helps regulate blood sugar levels by increasing insulin secretion and reducing the amount of glucose produced by the liver
Trigger neurologic symptoms, such as numbness and tingling in hands and feet, mood changes, anxiety, difficulty walking, disorientation, and memory loss
NSL literature pointer PMID 8596197 L-Carnitine laboratory index [PMID: 8596197] National Science Labs indexing note for PMID 8596197: review the PubMed methods, models, and limitations before citing
Medical services are delivered through OpenLoop Health